Sondo, Paul
Derra, Karim
Rouamba, Toussaint
Nakanabo Diallo, Seydou
Taconet, Paul
Kazienga, Adama
Ilboudo, Hamidou
Tahita, Marc Christian
Valéa, Innocent
Sorgho, Hermann
Lefèvre, Thierry
Tinto, Halidou
Funding for this research was provided by:
World Health Organization- Special Program for Research and Training in Tropical diseases
Sanofi
Institute of Tropical Medicine, Belgium (DGCD program)
Institut Mérieux, France (2018 Young Investigator Award)
Article History
Received: 8 April 2020
Accepted: 10 August 2020
First Online: 20 August 2020
Ethics approval and consent to participate
: The study was conducted in compliance with fundamental ethical principles and relevant regulations in Burkina Faso. The pharmacovigilance study protocol was approved by the Ethical Committee for health research in Burkina Faso (Deliberation N°2010-27, April 14th; 2010) prior to start of the study, and a signed/thumb printed inform consent was obtained from all participants before enrolment.
: Not applicable.
: The authors declare that they have no competing interests.